Overview

The Use of VSL#3 in Irritable Bowel Syndrome in Children

Status:
Terminated

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

The goal of this study is to determine whether the oral administration of the probiotic VSL#3 under randomized, placebo-controlled conditions will improve symptoms of irritable bowel syndrome in children, safely.

Phase:

Phase 1

Details

Lead Sponsor:

Dayton Children's Hospital

Collaborator:

National Institutes of Health (NIH)